Stratified by GLP-1 related and non GLP-1 related treatments In the included RCTs, GLP-1 related drugs (including liraglutide, semaglutide, beinaglutide, exenatide, and AMG133) showed significant weight regain compared with control group (WMD = 1.78 kg, 95% CI 0.76 to 2.80, P = 0.006, I 2 = 85%)
Understanding the Key Differences: Mechanism of Action: Methylcobalamin/Semaglutide: As a GLP-1 receptor agonist, Methylcobalamin/Semaglutide primarily works by mimicking the GLP-1 hormone, which helps reduce appetite, manage blood sugar levels, and promote weight loss
Their biggest similarities: They both affect appetite and fullness
No need to navigate crowded clinics or overbooked specialists